Interpace Biosciences, Inc.

UBS Group AG IDXG

Report date

12/31/2020

Quarter

2020 Q4

Filed

2/11/2021

Shares

2,946

Value ($000)

9

Weight

0.0%

2020 Q1 - 2020 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q4	2/11/2021	9	0.0%	2,946	12/31/2020
2020 Q3	11/12/2020	11	0.0%	3,472	9/30/2020
2020 Q1	5/1/2020	7	0.0%	1,390	3/31/2020